CAMP and Kaposi's sarcoma: The expressions of HBD-3 and LL-37 were seen in the epidermis as well as in the dermis (neoformed vessels, spindle cells and inflammatory cells) (Figure 1D, 1H) with different scores of immunoreactivity in KS lesions (Figure 1).